- Home
- CNTX vs INTT Comparison
CNTX vs INTT Comparison
Compare CNTX & INTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- INTT
- Stock Information
- Founded
- CNTX 2015
- INTT 1981
- Country
- CNTX United States
- INTT United States
- Employees
- CNTX N/A
- INTT N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- INTT Semiconductors
- Sector
- CNTX Health Care
- INTT Technology
- Exchange
- CNTX Nasdaq
- INTT Nasdaq
- Market Cap
- CNTX 78.0M
- INTT 77.3M
- IPO Year
- CNTX 2021
- INTT 1997
- Fundamental
- Price
- CNTX $0.58
- INTT $6.93
- Analyst Decision
- CNTX Strong Buy
- INTT Strong Buy
- Analyst Count
- CNTX 4
- INTT 2
- Target Price
- CNTX $6.00
- INTT $12.00
- AVG Volume (30 Days)
- CNTX 390.0K
- INTT 35.7K
- Earning Date
- CNTX 08-06-2025
- INTT 08-01-2025
- Dividend Yield
- CNTX N/A
- INTT N/A
- EPS Growth
- CNTX N/A
- INTT N/A
- EPS
- CNTX N/A
- INTT N/A
- Revenue
- CNTX N/A
- INTT $127,503,000.00
- Revenue This Year
- CNTX N/A
- INTT N/A
- Revenue Next Year
- CNTX N/A
- INTT $10.07
- P/E Ratio
- CNTX N/A
- INTT N/A
- Revenue Growth
- CNTX N/A
- INTT 5.19
- 52 Week Low
- CNTX $0.49
- INTT $5.24
- 52 Week High
- CNTX $2.75
- INTT $11.92
- Technical
- Relative Strength Index (RSI)
- CNTX 44.00
- INTT 60.86
- Support Level
- CNTX $0.56
- INTT $6.73
- Resistance Level
- CNTX $0.63
- INTT $7.35
- Average True Range (ATR)
- CNTX 0.08
- INTT 0.33
- MACD
- CNTX 0.00
- INTT 0.06
- Stochastic Oscillator
- CNTX 27.68
- INTT 71.43
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About INTT inTest Corporation
inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). The company operates their business and sells its products both domestically and internationally.